Senior insider sale
Chief Executive Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$4.02M
99.48K shares
What this filing means
CEESAY ABRAHAM plans to sell 99.48K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $4.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001958244-26-000411
DirectorOfficer· Chief Executive Officer
Since Feb 2026
99.48K
Shares to sell
$4.02M
Approx. market value
99.48K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Acquired as compensation -- Performance Awards
Compensation
12/2/2022
99.48KTotal acquired99.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/2/2022 | Acquired as compensation -- Performance Awards Compensation | 99.48K | — |
| Total | 99.48K | ||
Planned & Completed Dispositions1
NASDPlanned
Units to sell
99.48K
Market value
$4.02M
6/29/2026
Total
Units
99.48K
Value
$4.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/29/2026 | 99.48K | $4.02M | NASD | Planned |
| Total | 99.48K | $4.02M | ||